Gufic BioSciences Ltd

BSE
GUFICBIO •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in Gufic BioSciences Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
66.92% Gain from 52W Low
13.9
TTM PE Ratio
Below industry Median
41
Price to Book Ratio
Above industry Median
6.6
Dividend yield 1yr %
0.03
TTM PEG Ratio
PEG TTM is much higher than 1
5.1
RSI
RSI is mid-range
49.3
MFI
MFI is mid-range
57.5

Gufic BioSciences Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Gufic BioSciences Ltd shareholding Pattern

Promoter
72.5%
Foreign Institutions
0.1%
Mutual Funds
2.1%
Domestic Institutions
2.2%
Public
25.2%
Promoter
72.5%
Foreign Institutions
0.5%
Mutual Funds
1.6%
Domestic Institutions
1.7%
Public
25.3%
Promoter
75%
Foreign Institutions
0.7%
Mutual Funds
1.5%
Domestic Institutions
1.6%
Public
22.6%
Promoter
75%
Foreign Institutions
0.7%
Mutual Funds
1%
Domestic Institutions
1.2%
Public
23.1%
Promoter
75%
Foreign Institutions
0.7%
Mutual Funds
1%
Domestic Institutions
1.2%
Public
23.1%
Promoter
75%
Foreign Institutions
0.2%
Mutual Funds
1%
Domestic Institutions
1.2%
Public
23.7%

Gufic BioSciences Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
7
Bearish Moving Averages
9
5Day EMA
356.60
10Day EMA
357.90
12Day EMA
357.80
20Day EMA
355.80
26Day EMA
353.50
50Day EMA
344.70
100Day EMA
332.70
200Day EMA
314.20
5Day SMA
358.40
10Day SMA
360.80
20Day SMA
358.20
30Day SMA
353.00
50Day SMA
342.30
100Day SMA
324.60
150Day SMA
326.60
200Day SMA
316.00
Delivery & Volume
Resistance & Support
353.92
Pivot
Resistance
First Resistance
356.73
Second Resistance
361.27
Third Resistance
364.08
Support
First Support
349.38
Second support
346.57
Third Support
342.03
Relative Strength Index
49.31
Money Flow Index
57.50
MACD
4.28
MACD Signal
6.18
Average True Range
13.03
Average Directional Index
18.22
Rate of Change (21)
-1.30
Rate of Change (125)
1.47
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Hikal Ltd.
4373.48
258.6
376.15
Indoco Remedies Ltd.
3135.58
286.5
416.95
Unichem Laboratories Ltd.
3724.82
374.1
616
Sequent Scientific Ltd.
3596.27
86.03
155.45
Gujarat Themis Biosyn Ltd.
-
-
-
Supriya Lifescience Ltd.
3299.39
231.05
424.8

Gufic BioSciences Ltd Company background

Founded in: 1984
Managing director: Jayesh P Choksi
Gufic Biosciences (GBL) was incorporated in Jul84. The Company is a result of a reverse merger of itself with Central Finance. The promoters of GBL took over Central Finance at Rs 4042 per share and then got GBL listed on BSE. Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Choksi and Gandhi family, the promoters of GBL, have a longstanding presence in the pharma industry. In 1960, the family set up a joint venture company called Lyka Labs. In 1976, they decided to part ways and the Choksi family took over the manufacturing facility and the Gufic group of companies was born. Initially known as Gujarat Fine Chemicals, the first foray of the Gufic group was in the manufacture of various bulk drugs. The company later entered the formulation market. Currently, the overall profile of GBL comprises ethical products, herbal products, consumer products and bulk drugs that are sold in the domestic and the international markets. Over the past several years, the company have a known reputation of creating brands that have vaulted to leadership positions in the category in which they have been marketed. To mention a few names: Shapers (sanitary napkins), Onergy, and Stretch nil.In the year 2000, the company issued Bonus Equity Shares in proportion of five Equity shares for every two Equity shares held.Gufic has divested brands in the ethical pharma business in a sellers market. The company plan to invest further in RD activities and aggressively enter the herbal product and consumer product segments, where it foresee a huge potential. While benefiting from the rich, traditional knowledge base in India, it would like to operate from an area of strength in the herbal products segment.In 202021, Gufic Lifesciences Private Limited amalgamated with the Company through the Scheme of Amalgamation which became effective from May 21, 2021. GUFIC UK LIMITED (GUL), a wholly owned subsidiary of the Company, was incorporated in United Kingdom on March 15, 2022. Similarly, in 2023, Gufic Ireland Limited (GIL) was incorporated on March 02, 2023.
Read More

Gufic BioSciences Ltd FAQs

The past 1-year return of Gufic BioSciences Ltd [GUFICBIO] share was 55.15. The Gufic BioSciences Ltd [GUFICBIO] share hit a 1-year low of Rs. 211 and a 1-year high of Rs. 387.

The Mutual Fund Shareholding was 2.08% at the end of .

You can easily buy Gufic BioSciences Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -